Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Exercise Pill Guarantees Fitness Gains Without the Need for Physical Exertion

Reading Time: < 1 minute

Scientists in the United States have made a groundbreaking discovery in the realm of fitness and health with the development of a potential game-changing drug known as SLU-PP-332. This innovative drug has the ability to mimic the physiological benefits of exercise without the need for any physical activity.

Presented at the American Chemical Society’s 2024 Spring meeting, researchers from Washington University, led by principal investigator Bahaa Elgendy, shared their exciting findings on the experimental drug. In early trials conducted on rodents, SLU-PP-332 showed promising results by enhancing muscle function, improving fitness levels, and boosting endurance, all without the animals having to engage in increased physical activity.

What sets SLU-PP-332 apart is its ability to target estrogen-related receptors (ERRs), which are crucial in regulating various metabolic processes associated with health and well-being. By simultaneously targeting multiple ERRs, this drug has the potential to enhance muscle endurance, promote fat loss, and trigger metabolic changes similar to those observed during endurance training.

While SLU-PP-332 may not completely replace the benefits of exercise, it offers hope for individuals who are unable to engage in regular physical activity due to age or certain medical conditions. The establishment of Pelago Pharmaceuticals, a startup founded by Elgendy and his team, signifies a significant step towards the clinical translation of SLU-PP-332 as an “exercise pill,” making fitness benefits more accessible to everyone.

With the potential to not only improve muscle health but also enhance brain function and combat age-related cognitive decline, SLU-PP-332 represents a promising advancement in the quest for an effective exercise alternative. The future looks bright for this innovative drug and the possibilities it holds for revolutionizing the way we approach fitness and well-being.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money